T here have been a plethora of guidelines developed over recent years to synthesize the evidence on the management of specific conditions. Many have been based on systematic reviews, though where these have not been undertaken, the evidence is generally strong. However, how do we develop guidelines when the traditional evidence of randomized controlled trials and quality observational studies is not available? This situation arose when the Lymphoedema Framework Project (LFP) wished to develop a best-practice document to guide practitioners in the appropriate management of patients suffering from all causes of lymphoedema in a variety of health care settings.
The LFP is a major initiative led by Christine Moffatt at the Centre for Research and Implementation of Clinical Practice (CRICP) at Thames Valley University, London. Its aims are to provide evidence of the magnitude of lymphoedema as a health problem, to determine the level of need, and to provide national guidance on service development and care for patients. The project is focused on supporting the development and evaluation of integrated primary care-based lymphoedema services in a number of participating health care providers in the United Kingdom (Primary Care Trusts [PCTs]).
A critical feature of the LFP is the partnership that has been established to enable the many different lymphoedema stakeholder groups to be represented in achieving consensus about a range of key issues. Working with CRICP are 4 groups: patients, organizations, professionals, and industry. The Lymphoedema Support Network, the national patient group, have been involved from the earliest stages to provide an essential perspective that ensures services meet patient needs. Participating PCTs provide an organizational view so critical to the development of lymphoedema services in today's changing National Health Service, and a wealth of professional experience and expertise is made available through the partnership with The British Lymphology Society. Involvement of the wound care and compression industry ensures that the most appropriate products are developed and made available to patients.
The process started with a national consensus conference held in April 2002, bringing together more than 130 people from a diverse range of backgrounds from within the lymphoedema community to build a shared picture of what was happening with lymphoedema at that time, to map out what good primary care-based services might look like, and to set an agenda for the way forward. Working groups were developed from this group to provide input into clinical/ service development; consultation; outcomes and education. These groups met regularly during the early stages of the project, and their work was disseminated widely for consultation.
A consensus approach to the development of best-practice guidance is recommended for measuring expert opinion where clinical trial literature is scant, conflicting, or unclear. 1 Systematic reviews had been conducted in 3 areas of patient management, and of these, the results were largely equivocal. Based on guidance from the Health Technology Assessment Programme (HTA), 2 a modified nominal group technique was adopted by the LFP. This approach was preferred because it allowed for mailed questionnaires to elicit private decisions and opinions, to allow for all voices to be heard.
To enhance credibility and aid eventual widespread adoption of the best-practice document, it was important that the composition of the clinical/ service development working group reflected the full range of people the best-practice document was intended to influence. The resulting heterogeneity provided the variety of perspectives and views that aided the exploration of areas of contention and uncertainty and promoted better group decision making.
To explore practice and generate recommendations for an agreed best-practice approach, clinical vignettes were prepared and the group was asked to describe how the patient should be managed in a primary care setting. The working group was also asked to address a set of questions about key areas of practice. Each vignette and set of questions was supported by the best available literature, systematic reviews, and national and international guidelines where they existed. Discussion by the group was conducted face-to-face to enable exploration, clarification, and dispute to take place. The first draft of the best-practice document was written from this process. To assist the review of the document, levels of evidence supporting the guidance included in the first draft were graded using a system based on the HTA model. This first draft was then reviewed by the total membership of all the working groups and, following this, was further scrutinized by 2 commissioned experts in the field, following which a second draft was produced.
Members of all the working groups were sent the second draft of the best-practice document and asked to consider 138 statements about aspects of care and management within the document that had been highlighted for clarification by the clinical/service development working group. Each statement was rated on a 4-point Likert-type scale where the member could record that he or she strongly agreed, agreed, disagreed, or strongly disagreed with the statement. For convenience, speed, and privacy, this part of the process was conducted online and the responses entered immediately into a database ready for analysis. A 95% agreement rate for each item was considered an acceptable level for inclusion in the next draft. The ground rules for this part of the process asked that any disagreement with a statement had to be justified by the member concerned so as to facilitate redrafting. In the event, 20 statements failed to achieve 95% agreement and were redrafted and further consultation was conducted until agreement was reached.
The final stage of the consensus process was the review of the best-practice document by an international panel of lymphoedema experts. This was a vitally important element because the international perspective has not only extended the document's scope and relevance but it has also enriched its content, perspective, and influence. It is a reflection of the rigorous process of consensus outlined here that the document has received endorsement from all international lymphology societies. 3 The use of consensus to develop a best-practice document may be necessary in other areas of health care due to lack of empirical evidence to support many aspects of practice. It is important that as part of the consensus process, a balance is achieved between the research evidence that does exist and the collective knowledge and expertise of those contributing. As part of this, it is vital that the process be a dynamic one and that the best-practice document be regularly reviewed and updated as new research emerges.
The Best-Practice document is available for download at: http://cricp.org.
